Please login to the form below
Stemcentrx
This page shows the latest Stemcentrx news and features for those working in and with pharma, biotech and healthcare.
Strike three for Rova-T has AbbVie cutting its losses
The drugmaker acquired Rova-T via its $9.8bn takeover of Stemcentrx three years ago, on the back of encouraging mid-stage clinical data with the drug in small cell lung ... At the time of the Stemcentrx acquisition Rova-T had been tipped as a possible
Latest news
-
AbbVie CEO Gonzalez defends Allergan takeover
including a $21bn takeover of Pharmacyclics and $9.8bn deal for Stemcentrx.
-
European biosimilars hit AbbVie’s Humira revenues in Q4
The company paid $5.8 billion to acquire the antibody drug conjugate and its developer Stemcentrx in 2016, and has already had to write off 4bn in asset impairment charges.
-
Bluebird and Celgene BCMA CAR-T kicks off ASCO
ADCs on show include Pfizer and AbbVie’s cofetuzumab pelidotin, a PTK7-targeting drug that was picked up by the latter via its 2-16 purchase of Stemcentrx, though that deal
-
AbbVie slumps on trial results for would-be blockbuster Rova-T
It was the main asset in the pharma group’s $10bn acquisition of Stemcentrx in 2016.
-
Trial of AbbVie's Rova-T disappoints at ASCO
Rova-T was the centrepiece of AbbVie's acquisition of Stemcentrx, which closed last week and has been seen as an important piece in the company's attempts to build a ... The reception to the data seems to reflect the high expectations for the drug, which
More from news
Approximately 3 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
Deal Watch April 2016
Not content with the Stemcentrx acquisition, in April AbbVie also closed two other oncology deals:. ... Licensor/Acquisition target. Licensee/Acquirer. Deal type. Product technology. Headline $m. Stemcentrx (US).
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- How Resonant’s innovation and creativity resolve healthcare communications challenges
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Pfizer, Mylan move ahead with generics merger and spin-out
PMHub
Syneos Health®
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
